Scientists review recent evidence on the role of immune checkpoints in persistent HIV infection and discuss the potential for employing immune checkpoint blockade as a therapeutic approach to target HIV persistence on antiretroviral therapy.
[Ebiomedicine]
Sorry, but the selected Zotpress account can't be found.
